摘要:
The invention provides a method for the treatment of a patient having a more severe form of Alzheimer's disease (AD), where the severe form of AD is characterized by pathogenic deposits of amyloid beta peptide (Aβ), comprising the administration of an immunogenic fragment of Aβ capable of inducing an immune response in the form of antibodies to specific to the pathogenic deposits of Aβ and, in particular, to neurotoxic forms of Aβ including N-terminally truncated forms of Aβ. The invention further provides a method for selecting a suitable immunogenic fragment of Aβ for the treatment of a more severe form of AD.
摘要:
The invention relates to a method for the preparation of a stabilized cross-linked oligomer of amyloid beta using a near-zero length bifunctional cross-linking agent for use as an immunogen for the generation of antibodies for the treatment of Alzheimer's Disease and other conditions related to abnormal amyloid beta aggregation. A preferred bifunctional cross-linking agent is 1,5-difluoro-2,4-dinitrobenzene (DFDNB).
摘要:
Pharmaceutical compositions which comprise HIV Nef DNA vaccines are disclosed, along with the production and use of these DNA vaccines. The nef-based DNA vaccines of the invention are administered directly introduced into living vertebrate tissue, preferably humans, and express the HIV Nef protein or biologically relevant portions thereof, inducing a cellular immune response which specifically recognizes human immunodeficiency virus-1 (HIV-1). The DNA molecules which comprise the open reading frame of these DNA vaccines are synthetic DNA molecules encoding codon optimized HIV-1 Nef and derivatives of optimized HIV-1 Nef, including nef modifications comprising amino terminal leader peptides, removal of the amino terminal myristylation site, and/or modification of the Nef dileucine motif. These modifications may effect wild type characteristics of Nef, such as myristylation and down regulation of host CD4.
摘要:
The present invention relates an antifouling electrocatalytic composite membrane and a membrane reactor. The electrocatalytic composite membrane (3) consists of a substrate and a catalytic coating, wherein the substrate is selected from a conductive substrate or a nonconductive substrate coated with a conductive coating, and the substrate is a porous support having supporting, conducting and separating functions. The catalytic coating is supported or coated on the surface and in the pores of the conductive substrate or the conductive coating so as to increase the electrocatalytic activity of the substrate. The membrane reactor provides a trans-membrane pressure as the membrane separation power generated by a pump (7) and dead-end filtration or cross-flow filtration is applied, then the feed liquid permeates through the membrane from one side to the other to achieve the separation of the liquid; meanwhile, an electrocatalytic composite membrane (3) as anode and an auxiliary electrode (4) as cathode are connected to a power supply (1) separately by conducting wires (2) so that an electrolysis apparatus is formed. The electrocatalytic composite membrane (3) has a self-cleaning function and achieves the pollution-free operation during the membrane separation.
摘要:
The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLs, and tauphosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42.
摘要:
The invention provides compositions and methods for the treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient, such as Alzheimer's disease. Such methods entail administering an immunogenic fragment of Aβ, lacking a T-cell epitope, capable of inducing a beneficial immune response in the form of antibodies to Aβ. In another aspect, the immunogenic fragment of Aβ is capable of elevating plasma Aβ levels. The immunogenic fragments comprise linear or multivalent peptides of Aβ. Pharmaceutical compositions comprise the immunogenic fragment chemically linked to a carrier molecule which may be administered with an adjuvant.
摘要:
The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLs, and tauphosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42.
摘要:
The present invention relates an antifouling electrocatalytic composite membrane and a membrane reactor. The electrocatalytic composite membrane (3) consists of a substrate and a catalytic coating, wherein the substrate is selected from a conductive substrate or a nonconductive substrate coated with a conductive coating, and the substrate is a porous support having supporting, conducting and separating functions. The catalytic coating is supported or coated on the surface and in the pores of the conductive substrate or the conductive coating so as to increase the electrocatalytic activity of the substrate. The membrane reactor provides a trans-membrane pressure as the membrane separation power generated by a pump (7) and dead-end filtration or cross-flow filtration is applied, then the feed liquid permeates through the membrane from one side to the other to achieve the separation of the liquid; meanwhile, an electrocatalytic composite membrane (3) as anode and an auxiliary electrode (4) as cathode are connected to a power supply (1) separately by conducting wires (2) so that an electrolysis apparatus is formed. The electrocatalytic composite membrane (3) has a self-cleaning function and achieves the pollution-free operation during the membrane separation.
摘要:
The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLs, and tau phosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42.
摘要:
The present invention features live, attenuated respiratory syncytial viruses (RSV) useful as vaccines against RSV infection and/or the development of severe RSV-associated illnesses. The disclosed viruses are attenuated to the extent of being nonpathogenic when administered to a subject but substantially retain the antigenic and immunogenic properties of wild-type RSV.